11 drug(s) with this reaction
6,981 total reports
Headache has been reported as an adverse reaction across 11 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 6,981 adverse event reports mention headache in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with headache, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have headache listed in their FDA adverse event reports, sorted by report count:
In addition to headache, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
11 drug(s) manufactured by Chattem Inc have headache listed in their FDA adverse event reports: LIDOCAINE, MENTHOL, TRIAMCINOLONE ACETONIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, MENTHOL, and others.
There are a combined 6,981 reports of headache across 11 Chattem Inc drug(s) in the FDA adverse event database.